Skip to main content
. 2016 Aug 11;11(8):e0160351. doi: 10.1371/journal.pone.0160351

Fig 3. Cost-effectiveness acceptability frontier (CEAF) indicating the probability of the optimal test-treat strategy being cost-effective across different willingness to pay thresholds per additional quality-adjusted life-year (QALY).

Fig 3